Preliminary Program June 25

Time

13:00-14:00

Hall 1

Opening ceremony

Greetings from Representatives
 
Michael Roden (Düsseldorf, Germany)
Opening

Jühling Prize Ceremony*

Michael Roden (Düsseldorf, Germany)
Laudatio

Jühling Prize and Jühling Lecture*

Péter Kempler (Budapest, Hungary)
A short journey to no man’s land

Jühling Award 2025: Report*

Georgia Xourafa, Rita Vesce
(both Düsseldorf, Germany)

Jühling Award 2026*

*A Jühling Foundation event

Hall 2

Time

14:00-15:00

Hall 1

Session 1: CEDA/EASD Symposium

Chairs: Michael Roden (Düsseldorf, Germany), Anca Pantea-Stoian (Bucharest, Romania)

Francesco Giorgino (Bari, Italy)
Impact of obesity on development and progression of type 2 diabetes

Hindrik Mulder (Lund, Sweden)
Translating genetic signals into the pathophysiology of type 2 diabetes

Patrick Schrauwen (Düsseldorf, Germany)
Chronobiology and type 2 diabetes: does time matter?

Hall 2

Session 2: Diabetes Technology

Chairs: Helmut Schatz (Bochum, Germany), Andrej Janez (Ljubljana, Slovenia)

Latife Bozkurt (Vienna, Austria)
Continuous glucose monitoring and hybrid closed-loop systems in pregnancy with type 1 diabetes

Julia Mader (Graz, Austria)
Beyond Glucose: Emerging Biosensors for Comprehensive Metabolic Monitoring

Tim Heise (Neuss, Germany)
New developments in insulin formulations

Time

15:30-17:00

Hall 1

Session 3: Steatotic Liver Disease

Chairs: Francesco Giorgino (Bari, Italy), Sabine Kahl (Düsseldorf, Germany)

Eckhard Lammert (Düsseldorf, Germany)
Novel pathophysiology: MASLD and angiokines

Michael Roden (Düsseldorf, Germany)
Detecting and phenotyping MASLD

Dídac Mauricio (Barcelona, Spain)
Multifactorial approach to MASH

Christos Mantzoros (Boston, USA)
Diabetes and MASLD: the central role of the diabetologist

Hall 2

Session 4: Type 1 Diabetes

Chairs: Julia Mader (Graz, Austria), Adam Kretowski (Bialystok, Poland)

Clara Möser (Düsseldorf, Germany)
From Physiology to Algorithms: Managing Exercise in Type 1 Diabetes

Tomasz Klupa (Krakow, Poland)
Continuous glucose monitoring: does the quality of the device matter?

Thomas Meissner (Düsseldorf, Germany)
Adherence in adolescents with type 1 diabetes: how to enhance engagement

Reinhard Holl (Ulm, Germany)
Heterogeneity of type 1 diabetes

Time

17:00-18:00

Hall 1

Industry Session 1: Novo Nordisk Pharma

Hall 2

Time

18:00-19:00

Hall 1

Industry Session 2: Lilly

Hall 2